| Dr Marco A Camuzzi, DO | |
|
2865 Chancery Ln, Clearwater, FL 33759-1427 | |
| (727) 631-3756 | |
| Not Available |
| Full Name | Dr Marco A Camuzzi |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 2865 Chancery Ln, Clearwater, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164460770 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | OS9399 (Florida) | Primary |
| Entity Name | Lakeland Regional Health Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497748743 PECOS PAC ID: 8325952914 Enrollment ID: O20031118000384 |
News Archive
A supplemental "boost" of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with Ductal Carcinoma In Situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) following lumpectomy, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A. Inc. today announced the filing of a supplemental new drug application (sNDA) with the US Food and Drug Administration (FDA) seeking approval for a new indication for AMITIZA (lubiprostone) for the treatment of opioid-induced constipation (OIC) in patients with chronic, non-cancer pain.
Researchers open the way for improved study of hepatitis C virus by devising a novel virus culture system that allows replication of patient-isolated virus in nontransformed hepatocytes, instead of culture-adapted virus strains in transformed cell lines.
In what is being described as an "unexpected finding," new research suggests no correlation between a patient's race and complications with acute appendicitis.
In a continuing effort to build a more sustainable business, OMNOVA Solutions today announced a price increase of up to $0.05/wet lb. ($0.10/dry lb.) on all styrene butadiene latex products to all served markets in the Americas.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marco A Camuzzi, DO 2865 Chancery Ln, Clearwater, FL 33759-1427 Ph: (727) 631-3756 | Dr Marco A Camuzzi, DO 2865 Chancery Ln, Clearwater, FL 33759-1427 Ph: (727) 631-3756 |
News Archive
A supplemental "boost" of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with Ductal Carcinoma In Situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) following lumpectomy, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A. Inc. today announced the filing of a supplemental new drug application (sNDA) with the US Food and Drug Administration (FDA) seeking approval for a new indication for AMITIZA (lubiprostone) for the treatment of opioid-induced constipation (OIC) in patients with chronic, non-cancer pain.
Researchers open the way for improved study of hepatitis C virus by devising a novel virus culture system that allows replication of patient-isolated virus in nontransformed hepatocytes, instead of culture-adapted virus strains in transformed cell lines.
In what is being described as an "unexpected finding," new research suggests no correlation between a patient's race and complications with acute appendicitis.
In a continuing effort to build a more sustainable business, OMNOVA Solutions today announced a price increase of up to $0.05/wet lb. ($0.10/dry lb.) on all styrene butadiene latex products to all served markets in the Americas.
› Verified 8 days ago
Dr. Craig Stanley Barkley, M.D. Urology Medicare: May Accept Medicare Assignments Practice Location: 430 Morton Plant St, Suite 206, Clearwater, FL 33756 Phone: 727-441-1508 Fax: 727-443-7780 |